These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 27192187
1. Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014. Azman AS, Rumunu J, Abubakar A, West H, Ciglenecki I, Helderman T, Wamala JF, Vázquez Ode L, Perea W, Sack DA, Legros D, Martin S, Lessler J, Luquero FJ. Emerg Infect Dis; 2016 Jun; 22(6):1067-70. PubMed ID: 27192187 [Abstract] [Full Text] [Related]
2. Immune Responses to an Oral Cholera Vaccine in Internally Displaced Persons in South Sudan. Iyer AS, Bouhenia M, Rumunu J, Abubakar A, Gruninger RJ, Pita J, Lino RL, Deng LL, Wamala JF, Ryan ET, Martin S, Legros D, Lessler J, Sack DA, Luquero FJ, Leung DT, Azman AS. Sci Rep; 2016 Oct 24; 6():35742. PubMed ID: 27775046 [Abstract] [Full Text] [Related]
5. Neighborhood-targeted and case-triggered use of a single dose of oral cholera vaccine in an urban setting: Feasibility and vaccine coverage. Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Muller V, Llosa AE, Uzzeni F, Luquero FJ, Ciglenecki I, Azman AS. PLoS Negl Trop Dis; 2017 Jun 24; 11(6):e0005652. PubMed ID: 28594891 [Abstract] [Full Text] [Related]
6. Epidemiological description of a protracted cholera outbreak in Tonj East and Tonj North counties, former Warrap State, South Sudan, May-Oct 2017. Nsubuga F, Garang SC, Tut M, Oguttu D, Lubajo R, Lodiongo D, Lasuba M, Mpairwe A. BMC Infect Dis; 2019 Jan 03; 19(1):4. PubMed ID: 30606126 [Abstract] [Full Text] [Related]
7. Adapting to the global shortage of cholera vaccines: targeted single dose cholera vaccine in response to an outbreak in South Sudan. Parker LA, Rumunu J, Jamet C, Kenyi Y, Lino RL, Wamala JF, Mpairwe AM, Ciglenecki I, Luquero FJ, Azman AS, Cabrol JC. Lancet Infect Dis; 2017 Apr 03; 17(4):e123-e127. PubMed ID: 28109819 [Abstract] [Full Text] [Related]
17. The vaccine candidate Vibrio cholerae 638 is protective against cholera in healthy volunteers. García L, Jidy MD, García H, Rodríguez BL, Fernández R, Año G, Cedré B, Valmaseda T, Suzarte E, Ramírez M, Pino Y, Campos J, Menéndez J, Valera R, González D, González I, Pérez O, Serrano T, Lastre M, Miralles F, Del Campo J, Maestre JL, Pérez JL, Talavera A, Pérez A, Marrero K, Ledón T, Fando R. Infect Immun; 2005 May 03; 73(5):3018-24. PubMed ID: 15845509 [Abstract] [Full Text] [Related]
18. Evidence that inactivated oral cholera vaccines both prevent and mitigate Vibrio cholerae O1 infections in a cholera-endemic area. Clemens JD, Sack DA, Rao MR, Chakraborty J, Khan MR, Kay B, Ahmed F, Banik AK, van Loon FP, Yunus M. J Infect Dis; 1992 Nov 03; 166(5):1029-34. PubMed ID: 1402014 [Abstract] [Full Text] [Related]
19. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Legros D, Paquet C, Perea W, Marty I, Mugisha NK, Royer H, Neira M, Ivanoff B. Bull World Health Organ; 1999 Nov 03; 77(10):837-42. PubMed ID: 10593032 [Abstract] [Full Text] [Related]